ADENOVIRUS FLT3 LIGAND INDUCES NALT DCs FOR SALIVARY GLAND S-lgA Ab RESPONSES
腺病毒 FLT3 配体诱导 NALT DC 产生唾液腺 S-IgA Ab 反应
基本信息
- 批准号:7840769
- 负责人:
- 金额:$ 1.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-06-01 至 2010-05-31
- 项目状态:已结题
- 来源:
- 关键词:AdenovirusesAdjuvantAmylasesAntibodiesAntigensB-LymphocytesCCL2 geneCD4 Positive T LymphocytesCell Migration InductionCellsCholera ToxinComplementary DNACpG dinucleotideDendritic CellsEnvironmentFLT3 ligandFrequenciesGrantITGAM geneITGAX geneImmuneImmune responseImmunizationImmunoglobulin AImmunoglobulinsInterleukin-7IntestinesLamina PropriaLigandsLymphoid TissueMemoryMonocyte Chemoattractant ProteinsMusNosePlasmidsPlayPopulationProcessRegulationResearch PersonnelRoleSalivaSalivarySalivary GlandsSalivary immunoglobulin ASecretory Immunoglobulin ASterilitySubmandibular glandSurfaceSystemT-LymphocyteTLR4 geneTestingTissuesToll-like receptorsTransgenic Micebasechemokine receptorcommensal microbescytokinemigrationprogramspromoterreceptor expressionresponsesalivary celltrinitrophenyl-lipopolysaccharide
项目摘要
DESCRIPTION (provided by applicant): Over the past five years, we have studied the innate factors and immune cells which induce and regulate salivary secretory immunoglobulin (S-lgA) antibody (Ab) responses. We have shown that plasmids encoding the flt3 ligand (FL), lymphotactin (LTN), RANTES and MCP-1 cDNA as well as unmethylated cytosine-guanine dinucleotides oligodeoxynucleotide (CpG ODN), when used as nasal adjuvants, enhance both mucosal and systemic immune responses. Nasopharyngeal-associated lymphoreticular tissues (NALT) and the submandibular glands (SMGs) from mice given these nasal cDNA adjuvants showed increased numbers of dendritic cells (DCs) and were a key factor in the induction of salivary S-lgA Ab responses. Further, our recent study using an adenovirus (Ad) expressing FL cDNA (pFL) when used as nasal adjuvant significantly enhanced salivary S-lgA Ab responses. Based upon these findings, our overall hypothesis in this renewal application is that NALT DCs regulate salivary S-lgA Ab responses by processing Ag followed by their migration into the SMGs. More specifically, we hypothesize that targeting NALT with FL-based adjuvants will preferentially induce migration of NALT DCs into the SMGs and enhance the induction of mucosal S-lgA Ab responses. Our recent study showed that T cell-independent (Tl) Ag-specific salivary S- IgA Ab responses correlated with an increased number of B-1 B cells in the SMGs when mice were immunized nasally with Tl Ag plus native cholera toxin. Further, we found that increased levels of Toll-like receptor four (TLR4) expression by 78 T cells in the SMGs of mice given nasal Tl Ag. These results clearly showed that cross-talk between innate- and acquired-type immune cells was important in the induction of Ag-specific salivary S-lgA Ab responses even for immune responses to Tl Ags. We hypothesize that targeting NALT with FL-based adjuvants induce migration of NALT DCs to the SMGs that interact with B-1 B cells and y& T cells in the SMGs for the induction of mucosal S-lgA Ab responses. In order to test our hypothesis, we propose four Specific Aims. We will: 1) Characterization of chemokine receptor expression by Ad-FL-induced CD11b+ DCs in NALT for their maturation and their relocation into the SMGs. 2) Tracking Ad-FL-induced NALT DC migration for the induction of salivary S-lgA Ab responses. 3) Comparison of Ad- FL-induced NALT and SMG DCs for their immunological function in the induction of CD4'1' Th1- and Th2-type cytokine responses as well as long-lasting memory function. 4) Determination of the precise mechanism for cross-talk between Ad-FL-induced salivary DCs, B-1 B cells and yS T cells for salivary S-lgA Ab responses.
描述(由申请人提供):在过去的五年中,我们研究了诱导和调节唾液分泌免疫球蛋白(S-LGA)抗体(AB)抗体(AB)反应的先天因素和免疫细胞。我们已经表明,编码FLT3配体(FL),淋巴结蛋白(LTN),RANTES和MCP-1 cDNA以及未甲基化的细胞质 - 瓜烷二核苷酸寡氧化核苷酸(CPG ODN),用作NASASAL辅助剂,增强MICCANTES和Systome consical connance n andance clance和系统,质粒。给定这些鼻cDNA辅助剂的小鼠的鼻咽相关淋巴细胞组织(NALT)和下颌下腺(SMG)显示出增加的树突状细胞(DCS),并且是唾液S-LGA AB反应诱导的关键因素。此外,我们最近使用腺病毒(AD)表达FL cDNA(PFL)的研究显着增强了唾液S-LGA AB反应。基于这些发现,我们在此更新应用中的总体假设是,NALT DC通过处理Ag,然后将其迁移到SMG中来调节唾液S-LGA AB反应。更具体地说,我们假设用基于FL的佐剂靶向NALT将优先诱导NALT DC迁移到SMG中,并增强粘膜S-LGA AB反应的诱导。我们最近的研究表明,当小鼠用TL AG和天然霍乱毒素鼻鼻子免疫时,SMGS中的B-1 B细胞数量增加与SMG中的B-1 B细胞数量增加有关。此外,我们发现给定鼻TL Ag的小鼠SMG中78个T细胞的Toll样受体四(TLR4)表达增加。这些结果清楚地表明,先天性和获得性型免疫细胞之间的串扰在诱导Ag特异性唾液S-LGA AB反应中也很重要,即使对于对TL AGS的免疫反应也是如此。我们假设用基于FL的佐剂靶向NALT会诱导NALT DC迁移到SMG中与B-1 B细胞和Y&T细胞相互作用的SMG迁移,以诱导粘膜S-LGA AB反应。为了检验我们的假设,我们提出了四个具体目标。我们将:1)通过AD-FL诱导的NALT中的CD11b+ DC来表征趋化因子受体的表达,以使其成熟和迁移到SMG中。 2)跟踪AD-FL诱导的NALT DC迁移以诱导唾液S-LGA AB反应。 3)在诱导CD4'1'Th1-th1型细胞因子反应以及持久的记忆函数中,比较了Adfl诱导的NALT和SMG DC的免疫功能。 4)确定AD-FL诱导的唾液DC,B-1 B细胞和YS T细胞之间的精确机制,用于唾液S-LGA AB反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kohtaro Fujihashi其他文献
Kohtaro Fujihashi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kohtaro Fujihashi', 18)}}的其他基金
NALT-BASED ADJUVANTS FOR MUCOSAL IMMUNITY IN AGING
基于 NALT 的佐剂可增强衰老过程中的粘膜免疫能力
- 批准号:
7038822 - 财政年份:2006
- 资助金额:
$ 1.69万 - 项目类别:
NALT-BASED ADJUVANTS FOR MUCOSAL IMMUNITY IN AGING
基于 NALT 的佐剂可增强衰老过程中的粘膜免疫能力
- 批准号:
7904801 - 财政年份:2006
- 资助金额:
$ 1.69万 - 项目类别:
NALT-BASED ADJUVANTS FOR MUCOSAL IMMUNITY IN AGING
基于 NALT 的佐剂可增强衰老过程中的粘膜免疫能力
- 批准号:
7475766 - 财政年份:2006
- 资助金额:
$ 1.69万 - 项目类别:
NALT-BASED ADJUVANTS FOR MUCOSAL IMMUNITY IN AGING
基于 NALT 的佐剂可增强衰老过程中的粘膜免疫能力
- 批准号:
7291544 - 财政年份:2006
- 资助金额:
$ 1.69万 - 项目类别:
NALT-BASED ADJUVANTS FOR MUCOSAL IMMUNITY IN AGING
基于 NALT 的佐剂可增强衰老过程中的粘膜免疫能力
- 批准号:
7666083 - 财政年份:2006
- 资助金额:
$ 1.69万 - 项目类别:
Ab5 Toxins Nasal Adjuvant Target the Olfactory Bulbs/CNS
Ab5 毒素鼻佐剂靶向嗅球/中枢神经系统
- 批准号:
6711826 - 财政年份:2001
- 资助金额:
$ 1.69万 - 项目类别:
ADENOVIRUS FLT3 LIGAND INDUCES NALT DCs FOR SALIVARY GLAND S-lgA Ab RESPONSES
腺病毒 FLT3 配体诱导 NALT DC 产生唾液腺 S-IgA Ab 反应
- 批准号:
7848986 - 财政年份:1997
- 资助金额:
$ 1.69万 - 项目类别:
REGULATION OF ANTIGEN SPECIFIC SALIVARY IMMUNE RESPONSES
抗原特异性唾液免疫反应的调节
- 批准号:
2668269 - 财政年份:1997
- 资助金额:
$ 1.69万 - 项目类别:
REGULATION OF ANTIGEN SPECIFIC SALIVARY IMMUNE RESPONSES
抗原特异性唾液免疫反应的调节
- 批准号:
2882731 - 财政年份:1997
- 资助金额:
$ 1.69万 - 项目类别:
A ROLE FOR INNATE IMMUNITY IN SALIVARY IgA RESPONSES
先天免疫在唾液 IgA 反应中的作用
- 批准号:
6697270 - 财政年份:1997
- 资助金额:
$ 1.69万 - 项目类别:
相似国自然基金
穿透性靶向胰腺癌内cDC1的纳米佐剂调控溶酶体逃逸促进放疗诱导ICD的机制研究
- 批准号:82303680
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多级改造的工程化外泌体自佐剂疫苗平台实现鼻上皮细胞感染拟态和粘膜递送的研究
- 批准号:32371440
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
展示PD-L1抗体的纳米锰佐剂联合放疗以诱导原位肿瘤疫苗的产生及其机制的探究
- 批准号:32371518
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
靶向FPPS的双磷酸疫苗佐剂的开发
- 批准号:82341040
- 批准年份:2023
- 资助金额:100 万元
- 项目类别:专项基金项目
应用于冠状病毒广谱疫苗开发的新型全链式免疫增强型佐剂研究
- 批准号:82341036
- 批准年份:2023
- 资助金额:110 万元
- 项目类别:专项基金项目
相似海外基金
Novel oral delivery system for subunit vaccine against ETEC
针对 ETEC 亚单位疫苗的新型口服给药系统
- 批准号:
9770724 - 财政年份:2019
- 资助金额:
$ 1.69万 - 项目类别:
Adenosine Receptors and Restoration of Salivary Gland in Sjogren's Syndrome
腺苷受体与干燥综合征唾液腺的恢复
- 批准号:
8390609 - 财政年份:2012
- 资助金额:
$ 1.69万 - 项目类别:
Adenosine Receptors and Restoration of Salivary Gland in Sjogren's Syndrome
腺苷受体与干燥综合征唾液腺的恢复
- 批准号:
8508243 - 财政年份:2012
- 资助金额:
$ 1.69万 - 项目类别:
ADENOVIRUS FLT3 LIGAND INDUCES NALT DCs FOR SALIVARY GLAND S-lgA Ab RESPONSES
腺病毒 FLT3 配体诱导 NALT DC 产生唾液腺 S-IgA Ab 反应
- 批准号:
7848986 - 财政年份:1997
- 资助金额:
$ 1.69万 - 项目类别:
ADENOVIRUS FLT3 LIGAND INDUCES NALT DCs FOR SALIVARY GLAND S-lgA Ab RESPONSES
腺病毒 FLT3 配体诱导 NALT DC 产生唾液腺 S-IgA Ab 反应
- 批准号:
7467392 - 财政年份:1997
- 资助金额:
$ 1.69万 - 项目类别: